<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35632423</PMID><DateRevised><Year>2023</Year><Month>03</Month><Day>08</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-393X</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><Issue>5</Issue><PubDate><Year>2022</Year><Month>Apr</Month><Day>22</Day></PubDate></JournalIssue><Title>Vaccines</Title><ISOAbbreviation>Vaccines (Basel)</ISOAbbreviation></Journal><ArticleTitle>Comparison of High-Performance Liquid Chromatography with Sucrose Density Gradient Ultracentrifugation for the Quantification of Foot-and-Mouth Disease Vaccine Antigens.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">667</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/vaccines10050667</ELocationID><Abstract><AbstractText>Foot-and-mouth disease (FMD) causes substantial economic losses in the livestock industry. The protective immunizing component of the FMD virus (FMDV) is a ribonucleoprotein particle with a sedimentation coefficient of 146S. Size-exclusion high-performance liquid chromatography (SE-HPLC) was introduced to replace sucrose density gradient ultracentrifugation (SDG), which is the gold standard for the quantification of FMDV 146S particles. SE-HPLC showed a pattern similar to that of SDG; however, the two methods resulted in different quantities for the same amount of 146S particles. This study aimed to identify the reason for this disparity and adjust the difference between the two methods by employing a standard material. While SE-HPLC displayed all the virus particles in the peak fraction by SDS-PAGE and Western blotting, the virus particles were widely dispersed in multiple fractions, including peak fractions in the SDG. To adjust the difference between the two methods, a stable surrogate virus, bovine enterovirus, was devised to draw a standard curve, and the gap was reduced to &lt;10%. To our knowledge, this is the first report to provide experimental evidence on the difference between SDG and SE-HPLC for the quantification of FMDV particles.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Ah-Young</ForeName><Initials>AY</Initials><Identifier Source="ORCID">0000-0003-0600-1816</Identifier><AffiliationInfo><Affiliation>Center for FMD Vaccine Research, Animal and Plant Quarantine Agency, Gyeonsangbuk-do, Gimcheon 39660, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Sun Young</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Center for FMD Vaccine Research, Animal and Plant Quarantine Agency, Gyeonsangbuk-do, Gimcheon 39660, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Sang Hyun</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Center for FMD Vaccine Research, Animal and Plant Quarantine Agency, Gyeonsangbuk-do, Gimcheon 39660, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Jae Young</ForeName><Initials>JY</Initials><AffiliationInfo><Affiliation>Center for FMD Vaccine Research, Animal and Plant Quarantine Agency, Gyeonsangbuk-do, Gimcheon 39660, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Jong Sook</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Center for FMD Vaccine Research, Animal and Plant Quarantine Agency, Gyeonsangbuk-do, Gimcheon 39660, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Eun-Sol</ForeName><Initials>ES</Initials><AffiliationInfo><Affiliation>Center for FMD Vaccine Research, Animal and Plant Quarantine Agency, Gyeonsangbuk-do, Gimcheon 39660, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Jong-Hyeon</ForeName><Initials>JH</Initials><Identifier Source="ORCID">0000-0003-0825-8121</Identifier><AffiliationInfo><Affiliation>Center for FMD Vaccine Research, Animal and Plant Quarantine Agency, Gyeonsangbuk-do, Gimcheon 39660, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ko</LastName><ForeName>Young-Joon</ForeName><Initials>YJ</Initials><Identifier Source="ORCID">0000-0002-3436-8175</Identifier><AffiliationInfo><Affiliation>Center for FMD Vaccine Research, Animal and Plant Quarantine Agency, Gyeonsangbuk-do, Gimcheon 39660, Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>B-1543386-2022-24-04</GrantID><Agency>Animal and Plant Quarantine Agency</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Vaccines (Basel)</MedlineTA><NlmUniqueID>101629355</NlmUniqueID><ISSNLinking>2076-393X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">bovine enterovirus (BEV)</Keyword><Keyword MajorTopicYN="N">foot-and-mouth disease virus (FMDV)</Keyword><Keyword MajorTopicYN="N">quantification</Keyword><Keyword MajorTopicYN="N">size-exclusion high-performance liquid chromatography (SE-HPLC)</Keyword><Keyword MajorTopicYN="N">sucrose density gradient ultracentrifugation (SDG)</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>3</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>4</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>4</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>5</Month><Day>28</Day><Hour>1</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>5</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>29</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>4</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35632423</ArticleId><ArticleId IdType="pmc">PMC9143565</ArticleId><ArticleId IdType="doi">10.3390/vaccines10050667</ArticleId><ArticleId IdType="pii">vaccines10050667</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Knight-Jones T.J.D., Rushton J. The economic impacts of foot and mouth disease—What are they, how big are they and where do they occur? Prev. Vet. Med. 2013;112:161–173. doi: 10.1016/j.prevetmed.2013.07.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.prevetmed.2013.07.013</ArticleId><ArticleId IdType="pmc">PMC3989032</ArticleId><ArticleId IdType="pubmed">23958457</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma G.K., Mohapatra J.K., Mahajan S., Matura R., Subramanaim S., Pattnaik B. Comparative evaluation of non-structural protein-antibody detecting ELISAs for foot-and-mouth disease sero-surveillance under intensive vaccination. J. Virol. Methods. 2014;207:22–28. doi: 10.1016/j.jviromet.2014.06.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2014.06.022</ArticleId><ArticleId IdType="pubmed">24996132</ArticleId></ArticleIdList></Reference><Reference><Citation>Grubman M.J., Baxt B. Foot-and-Mouth Disease. Clin. Microbiol. Rev. 2004;17:465–493. doi: 10.1128/CMR.17.2.465-493.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.17.2.465-493.2004</ArticleId><ArticleId IdType="pmc">PMC387408</ArticleId><ArticleId IdType="pubmed">15084510</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z., Shao J., Zhao F., Zhou G., Gao S., Liu W., Lv J., Li X., Li Y., Chang H., et al. Chemiluminescence Immunoassay for the Detection of Antibodies against the 2C and 3ABC Nonstructural Proteins Induced by Infecting Pigs with Foot-and-Mouth Disease Virus. Clin. Vaccine Immunol. 2017;24:e00153-17. doi: 10.1128/CVI.00153-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CVI.00153-17</ArticleId><ArticleId IdType="pmc">PMC5583468</ArticleId><ArticleId IdType="pubmed">28592628</ArticleId></ArticleIdList></Reference><Reference><Citation>Rueckert R.R., Wimmer E. Systematic nomenclature of picornavirus proteins. J. Virol. 1984;50:957–959. doi: 10.1128/jvi.50.3.957-959.1984.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.50.3.957-959.1984</ArticleId><ArticleId IdType="pmc">PMC255765</ArticleId><ArticleId IdType="pubmed">6726891</ArticleId></ArticleIdList></Reference><Reference><Citation>Mason P.W., Grubman M.J., Baxt B. Molecular basis of pathogenesis of FMDV. Virus Res. 2003;91:9–32. doi: 10.1016/S0168-1702(02)00257-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0168-1702(02)00257-5</ArticleId><ArticleId IdType="pubmed">12527435</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuanfang F., Li P., Ma X., Lu Z., Sun P., Bai X., Zhang J., Bao H., Cao Y., Li D., et al. The pH stability of foot-and-mouth disease virus. Virol. J. 2017;14:233. doi: 10.1186/s12985-017-0897-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-017-0897-z</ArticleId><ArticleId IdType="pmc">PMC5706165</ArticleId><ArticleId IdType="pubmed">29183342</ArticleId></ArticleIdList></Reference><Reference><Citation>Doel T.R., Chong W.K.T. Comparative immunogenicity of 146S, 75S and 12S particles of foot-and-mouth disease virus. Arch. Virol. 1982;73:185–191. doi: 10.1007/BF01314726.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01314726</ArticleId><ArticleId IdType="pubmed">6293410</ArticleId></ArticleIdList></Reference><Reference><Citation>Doel T.R., Fletton B.W., Staple R.F. Further developments in the quantification of small RNA viruses by U.V. photometry of sucrose density gradients. Dev. Biol. Stand. 1981;50:209–219.</Citation><ArticleIdList><ArticleId IdType="pubmed">6281106</ArticleId></ArticleIdList></Reference><Reference><Citation>Raschke S., Guan J., Iliakis G. Application of Alkaline Sucrose Gradient Centrifugation in the Analysis of DNA Replication After DNA Damage. Methods Mol. Biol. 2009;521:329–342. doi: 10.1007/978-1-60327-815-7_18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-60327-815-7_18</ArticleId><ArticleId IdType="pubmed">19563115</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruiz V., Baztarrica J., Rybicki E.P., Meyers A.E., Wigdorovitz A. Minimally processed crude leaf extracts of Nicotiana benthamiana containing recombinant foot and mouth disease virus-like particles are immunogenic in mice. Biotechnol. Rep. 2018;20:e00283. doi: 10.1016/j.btre.2018.e00283.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.btre.2018.e00283</ArticleId><ArticleId IdType="pmc">PMC6180338</ArticleId><ArticleId IdType="pubmed">30319941</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim A.-Y., Park S.Y., Park S.H., Jin J.S., Kim E.-S., Kim J.Y., Park J.-H., Ko Y.-J. Validation of Pretreatment Methods for the In-Process Quantification of Foot-and-Mouth Disease Vaccine Antigens. Vaccines. 2021;9:1361. doi: 10.3390/vaccines9111361.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9111361</ArticleId><ArticleId IdType="pmc">PMC8624908</ArticleId><ArticleId IdType="pubmed">34835292</ArticleId></ArticleIdList></Reference><Reference><Citation>Spitteler M.A., Romo A., Magi N., Seo M.-G., Yun S.-J., Barroumeres F., Régulier E.G., Bellinzoni R. Validation of a high performance liquid chromatography method for quantitation of foot-and-mouth disease virus antigen in vaccines and vaccine manufacturing. Vaccine. 2019;37:5288–5296. doi: 10.1016/j.vaccine.2019.07.051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2019.07.051</ArticleId><ArticleId IdType="pubmed">31353259</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y., Li H., Li Z., Zhang Y., Zhang S., Chen Y., Yu M., Ma G., Su Z. Size-exclusion HPLC provides a simple, rapid, and versatile alternative method for quality control of vaccines by characterizing the assembly of antigens. Vaccine. 2015;33:1143–1150. doi: 10.1016/j.vaccine.2015.01.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2015.01.031</ArticleId><ArticleId IdType="pubmed">25604799</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks D.E., Haynes C.A., Hritcu D., Steels B.M., Müller W. Size exclusion chromatography does not require pores. Proc. Natl. Acad. Sci. USA. 2000;97:7064–7067. doi: 10.1073/pnas.120129097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.120129097</ArticleId><ArticleId IdType="pmc">PMC16499</ArticleId><ArticleId IdType="pubmed">10852951</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim M.-H., Yun S.-J., Kim Y.-H., Lee H.-S., Kim J.-Y., Kang J., Kim Y.-S., Seo M.-G., Kim J.-Y. Evaluation of Quality Control Methods for Foot-And-Mouth Disease Vaccines by High-Performance Liquid Chromatography. Pathogens. 2020;9:194. doi: 10.3390/pathogens9030194.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens9030194</ArticleId><ArticleId IdType="pmc">PMC7157562</ArticleId><ArticleId IdType="pubmed">32151048</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang J.-H., Lee G., Kim A., Park J.-H., Lee M., Kim B., Kim S.-M. A Vaccine Strain of the A/ASIA/Sea-97 Lineage of Foot-and-Mouth Disease Virus with a Single Amino Acid Substitution in the P1 Region That Is Adapted to Suspension Culture Provides High Immunogenicity. Vaccines. 2021;9:308. doi: 10.3390/vaccines9040308.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9040308</ArticleId><ArticleId IdType="pmc">PMC8063925</ArticleId><ArticleId IdType="pubmed">33805012</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee G., Hwang J.-H., Park J.-H., Lee M.J., Kim B., Kim S.-M. Vaccine strain of O/ME-SA/Ind-2001e of foot-and-mouth disease virus provides high immunogenicity and broad antigenic coverage. Antivir. Res. 2020;182:104920. doi: 10.1016/j.antiviral.2020.104920.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2020.104920</ArticleId><ArticleId IdType="pubmed">32828822</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko M.-K., Jo H.-E., Choi J.-H., You S.-H., Shin S.H., Jo H., Lee M.J., Kim S.-M., Kim B., Park J.-H. Improved foot-and-mouth disease vaccine with O PanAsia-2 strain protect pigs against O/Jincheon/SKR/2014 originated from South Korea. Vaccine. 2020;38:1120–1128. doi: 10.1016/j.vaccine.2019.11.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2019.11.029</ArticleId><ArticleId IdType="pubmed">31810782</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S.-Y., Lee Y.-J., Kim R.-H., Park J.-N., Park M.-E., Ko M.-K., Choi J.-H., Chu J.-Q., Lee K.-N., Kim S.-M., et al. Rapid Engineering of Foot-and-Mouth Disease Vaccine and Challenge Viruses. J. Virol. 2017;91:e00155-17. doi: 10.1128/JVI.00155-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00155-17</ArticleId><ArticleId IdType="pmc">PMC5533925</ArticleId><ArticleId IdType="pubmed">28566375</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu J.-Q., Lee Y.-J., Park J.-N., Kim S.-M., Lee K.-N., Ko Y.-J., Lee H.-S., Cho I.-S., Kim B., Park J.-H. Construction of a bovine enterovirus-based vector expressing a foot-and-mouth disease virus epitope. J. Virol. Methods. 2013;189:101–104. doi: 10.1016/j.jviromet.2013.01.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2013.01.010</ArticleId><ArticleId IdType="pubmed">23391822</ArticleId></ArticleIdList></Reference><Reference><Citation>Harmsen M.M., Fijten H.P., Westra D.F., Coco-Martin J.M. Effect of thiomersal on dissociation of intact (146S) foot-and-mouth disease virions into 12S particles as assessed by novel ELISAs specific for either 146S or 12S particles. Vaccine. 2011;29:2682–2690. doi: 10.1016/j.vaccine.2011.01.069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2011.01.069</ArticleId><ArticleId IdType="pubmed">21316500</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y., Zhao Q., Li Z., Sun L., Ma G., Zhang S., Su Z. Stabilization study of inactivated foot and mouth disease virus vaccine by size-exclusion HPLC and differential scanning calorimetry. Vaccine. 2017;35:2413–2419. doi: 10.1016/j.vaccine.2017.03.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2017.03.037</ArticleId><ArticleId IdType="pubmed">28342666</ArticleId></ArticleIdList></Reference><Reference><Citation>Effio C.L., Oelmeier S.A., Hubbuch J. High-throughput characterization of virus-like particles by interlaced size-exclusion chromatography. Vaccine. 2016;34:1259–1267. doi: 10.1016/j.vaccine.2016.01.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2016.01.035</ArticleId><ArticleId IdType="pubmed">26845741</ArticleId></ArticleIdList></Reference><Reference><Citation>Song Y., Yang Y., Lin X., Zhao Q., Li Z., Ma G., Su Z., Zhang S. On-line separation and quantification of virus antigens of different serotypes in multivalent vaccines by capillary zone electrophoresis: A case study for quality control of foot-and-mouth disease virus vaccines. J. Chromatogr. A. 2021;1637:461834. doi: 10.1016/j.chroma.2020.461834.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chroma.2020.461834</ArticleId><ArticleId IdType="pubmed">33383242</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren X., Zhang S., Gao X., Guo X., Xin T., Zhu H., Jia H., Hou S. Experimental immunization of mice with a recombinant bovine enterovirus vaccine expressing BVDV E0 protein elicits a long-lasting serologic response. Virol. J. 2020;17:88. doi: 10.1186/s12985-020-01338-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-020-01338-6</ArticleId><ArticleId IdType="pmc">PMC7331136</ArticleId><ArticleId IdType="pubmed">32611446</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., He J., Tang X., Zhang Z., Tian Y. A validated LC&amp;ndash;MS/MS method for simultaneous quantification of simvastatin and simvastatin acid in beagle plasma: Application to an absolute bioavailability study. Biomed. Chromatogr. 2021;36:e5290. doi: 10.1002/bmc.5290.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bmc.5290</ArticleId><ArticleId IdType="pubmed">34854096</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao D., Sun B., Sun S., Fu B., Liu C., Liu D., Chu Y., Ma Y., Bai L., Wu Y., et al. Characterization of human enterovirus71 virus-like particles used for vaccine antigens. PLoS ONE. 2017;12:e0181182. doi: 10.1371/journal.pone.0181182.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0181182</ArticleId><ArticleId IdType="pmc">PMC5521781</ArticleId><ArticleId IdType="pubmed">28732070</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>